Mountain Valley MD Commencing Trials in Bangladesh, Striking Pharmaceutical Production Agreements
News provided by
Share this article
Mountain Valley MD Holdings Inc. (the "
Company" or "
MVMD") (CSE: MVMD) (FRA: 20MP) (OTCQB: MVMDF) is pleased to announce it is commencing husbandry animal trials under the supervision of The People's Republic of Bangladesh's Ministry of Fisheries & Livestock for the Company's injectable solubilized Ivermectin technology, Ivectosol™ 1%.
"We are very excited to be welcoming Mountain Valley MD to The People's Republic of Bangladesh and are proud that they have selected our country for important research projects and as a key production hub for its solubilized Ivectosol™ 1% product," stated Bangladesh's Foreign Minister H.E. Dr. A. K. Abdul Momen, M.P.